Silver Creek Pharmaceuticals Inc San Francisco, CA - 94158

Silver Creek Pharmaceuticals Inc is categorized under Commercial Biotechnical Research in San Francisco, CA and active since 2010.

Silver Creek Pharmaceuticals Inc was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Ulrik Nielsen at the company’s single location by writing to 409 Illinois St, San Francisco, California CA 94158 or by phoning (415) 978-2178. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Silver Creek Pharmaceuticals Inc
Contact Person: Ulrik Nielsen
Address: 409 Illinois St, San Francisco, California 94158
Phone Number: (415) 978-2178
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Silver Creek Pharmaceuticals Inc was started in 2010 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Ulrik Nielsen for inquiries that concern Silver Creek Pharmaceuticals Inc by calling the company number (415) 978-2178, as your correspondence is most welcome. Additionally, the physical location of the single location of Silver Creek Pharmaceuticals Inc can be found at the coordinates 37.766695,-122.38797 as well as the street address 409 Illinois St in San Francisco, California 94158.

For its online presence, you may visit Silver Creek Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.